信达生物授出1.5万份购股权及14.82万股受限制股份

Core Viewpoint - The company, Sinopharm (01801), announced the granting of stock options and restricted shares to certain recipients as part of its 2024 share plan, pending acceptance by the recipients [1] Group 1 - The company granted 15,000 stock options to 3 recipients [1] - The company also granted 148,200 restricted shares to 29 recipients [1] - The grants are subject to acceptance by the recipients [1]